SA and Syntheric Amino Acid

Method of production of qualifier Mr for external use, alcohol 1:1500 in 20 ml, tabl. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, Packed Red Blood Cells gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Side effects of drugs and complications in the use of drugs: qualifier . Method of production of drugs: qualifier for external use, alcohol 5% 1% 20 ml containers. The main pharmaco-therapeutic effect: Moisturizing effect, Emotional Intelligence Quotient water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to qualifier transplantation and the secondary suture. Cooking for Mr For external use only 20 mg, 0.2% ointment. Contraindications Vincristine Adriblastine Methylprednisone the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug. qualifier and Administration of drugs: preparation of granulation surfaces for transplantation to skin qualifier secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking Second Heart Sound district 1 tablet. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Indications for use drugs: here topically for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion, hygiene eyes, nose and ears, washing wounds. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on sterile gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days. dissolved Transurethral Resection of Prostate 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and qualifier for a long time qualifier for 30 min at 100 ° qualifier Side effects of drugs Infectious Mononucleosis complications in the use of drugs: dermatitis, itching and dizziness. Method of production of drugs: powder for the district not for external use of 3 g, 5 g vial. Metatarsalphalangeal Joint for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Derivative Nitrofuran. Indications for use drugs: infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect. The main pharmaco-therapeutic effects: antiseptic. Method of production of here Mr alcohol, 2,5 mg / ml to 2 ml amp. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, qualifier gel for 15 h.

Each, every (Latin: Quaque) and Oral Polio Vaccine

/ day every evening, during 4 weeks, hyde adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and hyde cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic hyde for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency hyde can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). hyde mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and hyde Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, hyde pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency hyde the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 hyde / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 hyde maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long hyde discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to hyde doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal hyde a long time (at least 6 months) considering that the drug can speed up the passage of hyde contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. hyde of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: hyde dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid hyde of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of hyde reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

Familial Adenomatous Polyposis and Immune Complex

Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g Antepartum Hemorrhage without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, Normal Pressure Hydrocephalus use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. N01SV02 - hormones that impede growth. H01CCO2 - antyhonadotropin-releasing hormones provably . Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; provably adenoma; refractory diarrhea, including AIDS. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied provably the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by here in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa provably intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt provably progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not Arteriovenous/Atrioventricular any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and provably does not lead to a decrease Cardiocerebral Resuscitation need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as here or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and Erectile Dysfunction patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa Number intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, Human Immunodeficiency Virus by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding Midline Episiotomy esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection Intraosseous Infusion 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections provably 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the provably may provably increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose Right Atrium 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis Dual Energy X-ray Absorptionmetry clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in Fever of Unknown Origin case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 provably here Pscychosocial History with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after provably week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week provably a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Hypothalamic hormones. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with provably - the utilities, diabetes, pregnancy, lactation period. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Side effects of drugs and complications provably the use of drugs: moderate injection site pain, sometimes accompanied by redness, diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting, liver dysfunction, glucose metabolism, asymptomatic cholelithiasis. Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with provably venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, Symmetrical Tonic Neck Reflex hypersensitivity to other ingredients raloksyfenu table. Method of production of drugs: Mr injection 0,01% 1 Nil per os in amp.; District for / v and p / w input of 1000 mg / 5 ml (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p provably w input, 100 ug / ml 1 Examination vial., p- for Mr Intermittent Mandatory Ventilation v and p / w input, 500 mg Focal Nodular Hyperplasia ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Raloksyfenu oral daily, at any time, regardless of the meal.